Page last updated: 2024-12-07

o(6)-methyldeoxyguanylic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

O(6)-methyldeoxyguanylic acid: incorporated into DNA by DNA polymerase I & II [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID124999
CHEMBL ID1230511
MeSH IDM0070302

Synonyms (12)

Synonym
63642-13-7
CHEMBL1230511
mdgmp
9h-purin-2-amine, 9-(2-deoxy-5-o-phosphono-beta-d-erythro-pentofuranosyl)-6-methoxy-
o(6)-methyldeoxyguanylic acid
o(6)-methyldeoxyguanylic-acid
o(6)-methyldeoxyguanosine monophosphate
6-o-methyl guanosine-5'-monophosphate
9-(2-deoxy-5-o-phosphono-beta-d-erythro-pentofuranosyl)-6-methoxy-9h-purin-2-amine
DTXSID40979867
9-(2-deoxy-5-o-phosphonopentofuranosyl)-6-methoxy-3,9-dihydro-2h-purin-2-imine
Q27456489
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Adenosine deaminase-like proteinHomo sapiens (human)Km6.00006.00006.00006.0000AID612651
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (3)

Processvia Protein(s)Taxonomy
nucleotide metabolic processAdenosine deaminase-like proteinHomo sapiens (human)
inosine biosynthetic processAdenosine deaminase-like proteinHomo sapiens (human)
adenosine catabolic processAdenosine deaminase-like proteinHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (3)

Processvia Protein(s)Taxonomy
metal ion bindingAdenosine deaminase-like proteinHomo sapiens (human)
N6-methyl-AMP deaminase activityAdenosine deaminase-like proteinHomo sapiens (human)
adenosine deaminase activityAdenosine deaminase-like proteinHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (1)

Processvia Protein(s)Taxonomy
cytosolAdenosine deaminase-like proteinHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID612650Kcat/Km ratio of recombinant human ADAL1 expressed in Escherichia coli2011Journal of medicinal chemistry, Aug-25, Volume: 54, Issue:16
Adenosine deaminase-like protein 1 (ADAL1): characterization and substrate specificity in the hydrolysis of N(6)- or O(6)-substituted purine or 2-aminopurine nucleoside monophosphates.
AID612651Activity of recombinant human ADAL1 expressed in Escherichia coli by UV-spectrophotometry2011Journal of medicinal chemistry, Aug-25, Volume: 54, Issue:16
Adenosine deaminase-like protein 1 (ADAL1): characterization and substrate specificity in the hydrolysis of N(6)- or O(6)-substituted purine or 2-aminopurine nucleoside monophosphates.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (66.67)18.7374
1990's1 (16.67)18.2507
2000's0 (0.00)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.21

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.21 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.16 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.21)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]